Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical practice guidelines for IgG4-related sclerosing cholangitis.
Kamisawa T, Nakazawa T, Tazuma S, Zen Y, Tanaka A, Ohara H, Muraki T, Inui K, Inoue D, Nishino T, Naitoh I, Itoi T, Notohara K, Kanno A, Kubota K, Hirano K, Isayama H, Shimizu K, Tsuyuguchi T, Shimosegawa T, Kawa S, Chiba T, Okazaki K, Takikawa H, Kimura W, Unno M, Yoshida M. Kamisawa T, et al. Among authors: hirano k. J Hepatobiliary Pancreat Sci. 2019 Jan;26(1):9-42. doi: 10.1002/jhbp.596. Epub 2019 Jan 18. J Hepatobiliary Pancreat Sci. 2019. PMID: 30575336 Free PMC article.
Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012.
Ohara H, Okazaki K, Tsubouchi H, Inui K, Kawa S, Kamisawa T, Tazuma S, Uchida K, Hirano K, Yoshida H, Nishino T, Ko SB, Mizuno N, Hamano H, Kanno A, Notohara K, Hasebe O, Nakazawa T, Nakanuma Y, Takikawa H; Research Committee of IgG4-related Diseases; Research Committee of Intractable Diseases of Liver and Biliary Tract; Ministry of Health, Labor and Welfare, Japan; Japan Biliary Association. Ohara H, et al. Among authors: hirano k. J Hepatobiliary Pancreat Sci. 2012 Sep;19(5):536-42. doi: 10.1007/s00534-012-0521-y. J Hepatobiliary Pancreat Sci. 2012. PMID: 22717980
Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: a Japanese cohort.
Ohara H, Nakazawa T, Kawa S, Kamisawa T, Shimosegawa T, Uchida K, Hirano K, Nishino T, Hamano H, Kanno A, Notohara K, Hasebe O, Muraki T, Ishida E, Naitoh I, Okazaki K. Ohara H, et al. Among authors: hirano k. J Gastroenterol Hepatol. 2013 Jul;28(7):1247-51. doi: 10.1111/jgh.12248. J Gastroenterol Hepatol. 2013. PMID: 23621484
Clinical course of type 1 autoimmune pancreatitis patients without steroid treatment: a Japanese multicenter study of 97 patients.
Kubota K, Kamisawa T, Hirano K, Hirooka Y, Uchida K, Ikeura T, Shiomi H, Ohara H, Shimizu K, Arakura N, Kanno A, Sakagami J, Itoi T, Ito T, Ueki T, Nishino T, Inui K, Mizuno N, Yoshida H, Sugiyama M, Iwasaki E, Irisawa A, Okazaki K, Kawa S, Shimosegawa T, Takeyama Y, Chiba T. Kubota K, et al. Among authors: hirano k. J Hepatobiliary Pancreat Sci. 2018 Apr;25(4):223-230. doi: 10.1002/jhbp.541. Epub 2018 Mar 23. J Hepatobiliary Pancreat Sci. 2018. PMID: 29430861
Prognosis of primary sclerosing cholangitis according to age of onset.
Watanabe T, Nakai Y, Mizuno S, Hamada T, Kogure H, Hirano K, Akamatsu N, Hasegawa K, Isayama H, Koike K. Watanabe T, et al. Among authors: hirano k. J Hepatobiliary Pancreat Sci. 2021 Dec;28(12):1115-1120. doi: 10.1002/jhbp.952. Epub 2021 Apr 15. J Hepatobiliary Pancreat Sci. 2021. PMID: 33811469
Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 I. Concept and diagnosis of autoimmune pancreatitis.
Okazaki K, Kawa S, Kamisawa T, Ito T, Inui K, Irie H, Nishino T, Notohara K, Nishimori I, Tanaka S, Nishiyama T, Suda K, Shiratori K, Tanaka M, Shimosegawa T; Working Committee of the Japan Pancreas Society and the Research Committee for Intractable Pancreatic Disease supported by the Ministry of Health, Labour and Welfare of Japan. Okazaki K, et al. J Gastroenterol. 2014 Apr;49(4):567-88. doi: 10.1007/s00535-014-0942-2. Epub 2014 Mar 18. J Gastroenterol. 2014. PMID: 24639057
Short-term prognostic factors for primary sclerosing cholangitis.
Watanabe T, Hirano K, Tada M, Isayama H, Mizuno S, Arizumi T, Toda N, Sugawara Y, Kokudo N, Koike K. Watanabe T, et al. Among authors: hirano k. J Hepatobiliary Pancreat Sci. 2015 Jun;22(6):486-90. doi: 10.1002/jhbp.238. Epub 2015 Mar 31. J Hepatobiliary Pancreat Sci. 2015. PMID: 25826613
Prospective study of bezafibrate for the treatment of primary sclerosing cholangitis.
Mizuno S, Hirano K, Isayama H, Watanabe T, Yamamoto N, Nakai Y, Sasahira N, Tada M, Omata M, Koike K. Mizuno S, et al. Among authors: hirano k. J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):766-70. doi: 10.1002/jhbp.281. Epub 2015 Aug 21. J Hepatobiliary Pancreat Sci. 2015. PMID: 26173026 Clinical Trial.
Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients.
Kubota K, Kamisawa T, Okazaki K, Kawa S, Hirano K, Hirooka Y, Uchida K, Shiomi H, Ohara H, Shimizu K, Arakura N, Kanno A, Sakagami J, Itoi T, Ito T, Ueki T, Nishino T, Inui K, Mizuno N, Yoshida H, Sugiyama M, Iwasaki E, Irisawa A, Shimosegawa T, Takeyama Y, Chiba T. Kubota K, et al. Among authors: hirano k. J Gastroenterol. 2017 Aug;52(8):955-964. doi: 10.1007/s00535-016-1302-1. Epub 2017 Jan 6. J Gastroenterol. 2017. PMID: 28062947
Risk Factors for Pancreatic Stone Formation in Type 1 Autoimmune Pancreatitis: A Long-term Japanese Multicenter Analysis of 624 Patients.
Ito T, Kawa S, Matsumoto A, Kubota K, Kamisawa T, Okazaki K, Hirano K, Hirooka Y, Uchida K, Masuda A, Ohara H, Shimizu K, Arakura N, Masamune A, Kanno A, Sakagami J, Itoi T, Ito T, Ueki T, Nishino T, Inui K, Mizuno N, Yoshida H, Sugiyama M, Iwasaki E, Irisawa A, Shimosegawa T, Chiba T. Ito T, et al. Among authors: hirano k. Pancreas. 2019 Jan;48(1):49-54. doi: 10.1097/MPA.0000000000001210. Pancreas. 2019. PMID: 30540679
2,432 results